![Joanne Donovan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortune : 149 177 $ au 31/05/2026
Joanne M.
Donovan is currently Chief Medical Officer at Edgewise Therapeutics, Inc. since 2021.
Formerly, Dr. Donovan was Medical Director at GelTex Pharmaceuticals, Inc., Chief Medical Officer & SVP-Clinical Development at Astria Therapeutics, Inc. from 2011 to 2021, Associate Clinical Professor at Harvard Medical School, and Vice President-Clinical Development at Genzyme Corp.
from 1998 to 2011.
Education includes undergraduate, graduate, and doctorate degrees from Massachusetts Institute of Technology and a doctorate degree from Harvard Medical School.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 05/05/2026 | 4 367 ( 0% ) | 149 177 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| EDGEWISE THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 27/04/2021 |
| Sociétés | Poste | Fin |
|---|---|---|
| ASTRIA THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 23/04/2021 |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Directeur Technique/Scientifique/R&D | 01/07/2011 |
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
GelTex Pharmaceuticals, Inc.
 GelTex Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops non-absorbed, polymer-based pharmaceuticals | Directeur Technique/Scientifique/R&D | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 6 |
|---|---|
GelTex Pharmaceuticals, Inc.
GelTex Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops non-absorbed, polymer-based pharmaceuticals | Health Technology |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Astria Therapeutics, Inc.
 Astria Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes novel therapeutics for rare and niche allergic & immunological diseases | Health Technology |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Edgewise Therapeutics, Inc.
 Edgewise Therapeutics, Inc. BiotechnologyHealth Technology Develops novel therapies for skeletal muscle diseases | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
